CV Sciences (CVSI) Other Operating Expenses (2015 - 2022)
CV Sciences' (CVSI) quarterly Other Operating Expenses came in at $7000.0 in Q4 2022, up 146.67% year-on-year from $2837.8 in Q4 2021, and up 146.67% quarter-over-quarter from -$15000.0 in Q4 2021.
CV Sciences (CVSI) Other Operating Expenses (2015 - 2022) Analysis & Trends
CV Sciences has disclosed Other Operating Expenses across 4 years of filings, most recently posting $7000.0 for Q4 2022.
- Other Operating Expenses for Q4 2022 came in at $7000.0, up 146.67% year-over-year; the trailing twelve-month figure through Sep 2023 was $7000.0 (up 146.67% YoY), and the FY2022 annual result was $7000.0, up 146.67% from the prior year.
- Other Operating Expenses came in at $7000.0 for Q4 2022 at CV Sciences, up from -$15000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $7000.0 in Q4 2022 to a low of -$15000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 7,000.00 |
| Dec 31, 2021 | -15,000.00 |
| Dec 31, 2017 | 2.43 Mn |
| Sep 30, 2015 | 756,714.00 |